What You Missed

Medical device companies approach Providence Chief of Medicine Mahesh Mulumudi all the time. He discusses the obstacles you’ll face to make that sale.

Former CEO of Proove Biosciences Brian Meshkin shares valuable lessons from the crushing downfall of his medical device company – so you don’t make the same mistakes he did. 😟

U.S. and EU post-market surveillance experts, Christine Zomorodian and Anne Leijsen, lead this 10x Medical Device Conference talk on post-market data.

Sarah leads a team of 120 and tells us how ResMed uses its customer data to drive continuous improvement, patient satisfaction, and profits!

At 10x, Michael Drues and Jon Speer walk us through the implications of choosing the letter-to-file path versus the special 510(k) or PMA route.

Human factor analysis can mitigate user risk when developing a medical device innovation, explains MaryBeth Privitera from HS Design at 10x.